The flow cytometry analysis identified a predominance of atypical lymphoid-derived cells expressing markers commonly associated with B-cell lineage, such as CD19, CD22, and CD10, along with a high percentage of terminal deoxynucleotidyl transferase (TdT)-positive cells, confirming the diagnosis of B-ALL. The gene discussed is CD22; the disease is acute lymphoblastic leukemia.